LBA8_PRKEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; no. suppl_8
Main Authors	Burtness, B, Harrington, K J, Greil, R, Soulières, D, Tahara, M, De Castro, G, Psyrri, A, Baste Rotllan, N, Neupane, P C, Bratland, Å, Fuereder, T, Hughes, B G M, Mesia, R, Ngamphaiboon, N, Rordorf, T, Wan Ishak, W Z, Roy, A, Cheng, J, Jin, F, Rischin, D
Format	Journal Article
Language	English
Published	Oxford University Press 01.10.2018
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdy424.045